12D miR HR13_24
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tfdp1
|
ENSMUSG00000038482.10 | transcription factor Dp 1 |
Wt1
|
ENSMUSG00000016458.7 | Wilms tumor 1 homolog |
Egr2
|
ENSMUSG00000037868.9 | early growth response 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tfdp1 | mm10_v2_chr8_+_13339656_13339674 | 0.89 | 2.6e-04 | Click! |
Egr2 | mm10_v2_chr10_+_67535465_67535492 | 0.70 | 1.7e-02 | Click! |
Wt1 | mm10_v2_chr2_+_105130883_105130981 | -0.56 | 7.5e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_108275409 | 18.04 |
ENSMUST00000136175.1
|
Ccdc85c
|
coiled-coil domain containing 85C |
chr4_+_124657646 | 16.23 |
ENSMUST00000053491.7
|
Pou3f1
|
POU domain, class 3, transcription factor 1 |
chr11_+_77930800 | 15.40 |
ENSMUST00000093995.3
ENSMUST00000000646.7 |
Sez6
|
seizure related gene 6 |
chr7_+_46396439 | 12.94 |
ENSMUST00000025202.6
|
Kcnc1
|
potassium voltage gated channel, Shaw-related subfamily, member 1 |
chr6_+_120666388 | 11.65 |
ENSMUST00000112686.1
|
Cecr2
|
cat eye syndrome chromosome region, candidate 2 |
chr9_-_22052021 | 11.51 |
ENSMUST00000003501.7
|
Elavl3
|
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) |
chr12_+_109453455 | 11.20 |
ENSMUST00000109844.4
ENSMUST00000109842.2 ENSMUST00000109843.1 ENSMUST00000109846.4 ENSMUST00000173539.1 ENSMUST00000109841.2 |
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr4_+_122995944 | 10.82 |
ENSMUST00000106252.2
|
Mycl
|
v-myc myelocytomatosis viral oncogene homolog, lung carcinoma derived (avian) |
chr12_-_112929415 | 10.77 |
ENSMUST00000075827.3
|
Jag2
|
jagged 2 |
chr9_+_106453838 | 10.30 |
ENSMUST00000024260.6
|
Pcbp4
|
poly(rC) binding protein 4 |
chr11_+_79660532 | 10.12 |
ENSMUST00000155381.1
|
Rab11fip4
|
RAB11 family interacting protein 4 (class II) |
chr11_+_119942763 | 9.76 |
ENSMUST00000026436.3
ENSMUST00000106231.1 ENSMUST00000075180.5 ENSMUST00000103021.3 ENSMUST00000106233.1 |
Baiap2
|
brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr4_+_122996035 | 9.59 |
ENSMUST00000030407.7
|
Mycl
|
v-myc myelocytomatosis viral oncogene homolog, lung carcinoma derived (avian) |
chrX_-_73659724 | 9.26 |
ENSMUST00000114473.1
ENSMUST00000002087.7 |
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr9_+_55326913 | 9.04 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chr12_-_5375682 | 9.00 |
ENSMUST00000020958.8
|
Klhl29
|
kelch-like 29 |
chr4_+_129513581 | 8.97 |
ENSMUST00000062356.6
|
Marcksl1
|
MARCKS-like 1 |
chr10_+_40883819 | 8.89 |
ENSMUST00000105509.1
|
Wasf1
|
WAS protein family, member 1 |
chr5_+_110286306 | 8.72 |
ENSMUST00000007296.5
ENSMUST00000112482.1 |
Pole
|
polymerase (DNA directed), epsilon |
chr1_+_72824482 | 8.70 |
ENSMUST00000047328.4
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr19_+_6084983 | 8.59 |
ENSMUST00000025704.2
|
Cdca5
|
cell division cycle associated 5 |
chr19_+_7268296 | 8.58 |
ENSMUST00000066646.4
|
Rcor2
|
REST corepressor 2 |
chr18_-_77565050 | 8.51 |
ENSMUST00000182153.1
ENSMUST00000182146.1 ENSMUST00000026494.7 ENSMUST00000182024.1 |
Rnf165
|
ring finger protein 165 |
chr1_+_92831614 | 8.37 |
ENSMUST00000045970.6
|
Gpc1
|
glypican 1 |
chr7_+_29289300 | 8.28 |
ENSMUST00000048187.4
|
Ppp1r14a
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
chr7_-_38107490 | 8.18 |
ENSMUST00000108023.3
|
Ccne1
|
cyclin E1 |
chr9_+_107935876 | 8.00 |
ENSMUST00000035700.8
|
Camkv
|
CaM kinase-like vesicle-associated |
chr11_-_77489666 | 7.95 |
ENSMUST00000037593.7
ENSMUST00000092892.3 |
Ankrd13b
|
ankyrin repeat domain 13b |
chr5_-_33433976 | 7.78 |
ENSMUST00000173348.1
|
Nkx1-1
|
NK1 transcription factor related, locus 1 (Drosophila) |
chr15_+_26309039 | 7.70 |
ENSMUST00000140840.1
ENSMUST00000152841.1 |
March11
|
membrane-associated ring finger (C3HC4) 11 |
chr4_-_129121699 | 7.69 |
ENSMUST00000135763.1
ENSMUST00000149763.1 ENSMUST00000164649.1 |
Hpca
|
hippocalcin |
chr7_-_34812677 | 7.68 |
ENSMUST00000078686.6
|
Chst8
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 |
chr13_-_55329723 | 7.67 |
ENSMUST00000021941.7
|
Mxd3
|
Max dimerization protein 3 |
chr8_-_123859423 | 7.54 |
ENSMUST00000034452.5
|
Ccsap
|
centriole, cilia and spindle associated protein |
chr2_-_181135103 | 7.54 |
ENSMUST00000149964.2
ENSMUST00000103050.3 ENSMUST00000081528.6 ENSMUST00000049792.8 ENSMUST00000103048.3 ENSMUST00000103047.3 ENSMUST00000129073.1 ENSMUST00000144592.1 ENSMUST00000139458.1 ENSMUST00000154164.1 ENSMUST00000123336.1 ENSMUST00000129361.1 ENSMUST00000103051.2 |
Kcnq2
|
potassium voltage-gated channel, subfamily Q, member 2 |
chr17_-_25433775 | 7.52 |
ENSMUST00000159610.1
ENSMUST00000159048.1 ENSMUST00000078496.5 |
Cacna1h
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr1_-_33907721 | 7.49 |
ENSMUST00000115161.1
ENSMUST00000062289.8 |
Bend6
|
BEN domain containing 6 |
chr4_+_127169131 | 7.42 |
ENSMUST00000046659.7
|
Dlgap3
|
discs, large (Drosophila) homolog-associated protein 3 |
chr7_+_27258725 | 7.40 |
ENSMUST00000079258.6
|
Numbl
|
numb-like |
chr9_-_31913462 | 7.35 |
ENSMUST00000116615.3
|
Barx2
|
BarH-like homeobox 2 |
chr4_+_48585193 | 7.32 |
ENSMUST00000107703.1
|
Tmeff1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr17_-_25727364 | 7.29 |
ENSMUST00000170070.1
ENSMUST00000048054.7 |
Chtf18
|
CTF18, chromosome transmission fidelity factor 18 |
chr7_+_109010825 | 7.27 |
ENSMUST00000033341.5
|
Tub
|
tubby candidate gene |
chr17_-_24251382 | 7.18 |
ENSMUST00000115390.3
|
Ccnf
|
cyclin F |
chr3_-_89322883 | 7.17 |
ENSMUST00000029673.5
|
Efna3
|
ephrin A3 |
chr9_-_97018823 | 7.17 |
ENSMUST00000055433.4
|
Spsb4
|
splA/ryanodine receptor domain and SOCS box containing 4 |
chr7_+_29307924 | 7.13 |
ENSMUST00000108230.1
ENSMUST00000065181.5 |
Dpf1
|
D4, zinc and double PHD fingers family 1 |
chr5_-_135251209 | 6.94 |
ENSMUST00000062572.2
|
Fzd9
|
frizzled homolog 9 (Drosophila) |
chr4_+_48585135 | 6.87 |
ENSMUST00000030032.6
|
Tmeff1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr17_-_45686120 | 6.85 |
ENSMUST00000143907.1
ENSMUST00000127065.1 |
Tmem63b
|
transmembrane protein 63b |
chr10_-_80577285 | 6.84 |
ENSMUST00000038558.8
|
Klf16
|
Kruppel-like factor 16 |
chr2_+_91922178 | 6.81 |
ENSMUST00000170432.1
|
Chrm4
|
cholinergic receptor, muscarinic 4 |
chr17_+_46297406 | 6.73 |
ENSMUST00000061722.6
ENSMUST00000166280.1 |
Dlk2
|
delta-like 2 homolog (Drosophila) |
chr2_-_102451792 | 6.69 |
ENSMUST00000099678.3
|
Fjx1
|
four jointed box 1 (Drosophila) |
chr1_-_9700209 | 6.55 |
ENSMUST00000088658.4
|
Mybl1
|
myeloblastosis oncogene-like 1 |
chr11_-_72411695 | 6.54 |
ENSMUST00000108500.1
ENSMUST00000050226.6 |
Smtnl2
|
smoothelin-like 2 |
chr5_-_124249758 | 6.52 |
ENSMUST00000162812.1
|
Pitpnm2
|
phosphatidylinositol transfer protein, membrane-associated 2 |
chrX_-_73660047 | 6.45 |
ENSMUST00000114472.1
|
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr9_+_21032038 | 6.39 |
ENSMUST00000019616.4
|
Icam5
|
intercellular adhesion molecule 5, telencephalin |
chr4_+_48585276 | 6.36 |
ENSMUST00000123476.1
|
Tmeff1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr18_+_64340225 | 6.33 |
ENSMUST00000175965.2
ENSMUST00000115145.3 |
Onecut2
|
one cut domain, family member 2 |
chr4_+_11191726 | 6.31 |
ENSMUST00000029866.9
ENSMUST00000108324.3 |
Ccne2
|
cyclin E2 |
chr6_+_134929118 | 6.30 |
ENSMUST00000185152.1
ENSMUST00000184504.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr11_-_119547744 | 6.30 |
ENSMUST00000026670.4
|
Nptx1
|
neuronal pentraxin 1 |
chr4_-_129121234 | 6.24 |
ENSMUST00000030572.3
|
Hpca
|
hippocalcin |
chr7_-_139582790 | 6.19 |
ENSMUST00000106095.2
|
Nkx6-2
|
NK6 homeobox 2 |
chr2_-_122369130 | 6.12 |
ENSMUST00000151130.1
ENSMUST00000125826.1 |
Shf
|
Src homology 2 domain containing F |
chr2_-_180104463 | 6.11 |
ENSMUST00000056480.3
|
Hrh3
|
histamine receptor H3 |
chr15_-_66286224 | 6.04 |
ENSMUST00000070256.7
|
Kcnq3
|
potassium voltage-gated channel, subfamily Q, member 3 |
chr10_-_128891674 | 6.03 |
ENSMUST00000026408.6
|
Gdf11
|
growth differentiation factor 11 |
chr15_-_82212796 | 6.02 |
ENSMUST00000179269.1
|
AI848285
|
expressed sequence AI848285 |
chr2_+_127336152 | 6.01 |
ENSMUST00000028846.6
|
Dusp2
|
dual specificity phosphatase 2 |
chr6_+_4747306 | 6.01 |
ENSMUST00000175823.1
ENSMUST00000176204.1 ENSMUST00000166678.1 |
Peg10
|
paternally expressed 10 |
chr1_+_172481788 | 5.98 |
ENSMUST00000127052.1
|
Igsf9
|
immunoglobulin superfamily, member 9 |
chr5_+_33721724 | 5.96 |
ENSMUST00000067150.7
ENSMUST00000169212.2 ENSMUST00000114411.2 ENSMUST00000164207.3 |
Fgfr3
|
fibroblast growth factor receptor 3 |
chr15_+_78913916 | 5.96 |
ENSMUST00000089378.4
|
Pdxp
|
pyridoxal (pyridoxine, vitamin B6) phosphatase |
chr9_-_70141484 | 5.76 |
ENSMUST00000034749.8
|
Fam81a
|
family with sequence similarity 81, member A |
chr9_-_21760275 | 5.75 |
ENSMUST00000098942.4
|
Spc24
|
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
chr17_+_25717171 | 5.74 |
ENSMUST00000172002.1
|
Gng13
|
guanine nucleotide binding protein (G protein), gamma 13 |
chr5_-_96161990 | 5.72 |
ENSMUST00000155901.1
|
Cnot6l
|
CCR4-NOT transcription complex, subunit 6-like |
chr6_+_134929089 | 5.72 |
ENSMUST00000183867.1
ENSMUST00000184991.1 ENSMUST00000183905.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr7_+_101818306 | 5.72 |
ENSMUST00000008090.9
|
Phox2a
|
paired-like homeobox 2a |
chr7_-_127026479 | 5.69 |
ENSMUST00000032916.4
|
Maz
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr19_+_38055002 | 5.69 |
ENSMUST00000096096.4
ENSMUST00000116506.1 ENSMUST00000169673.1 |
Cep55
|
centrosomal protein 55 |
chrX_+_49470450 | 5.69 |
ENSMUST00000114904.3
|
Arhgap36
|
Rho GTPase activating protein 36 |
chr5_-_20882072 | 5.63 |
ENSMUST00000118174.1
|
Phtf2
|
putative homeodomain transcription factor 2 |
chrX_+_49470555 | 5.62 |
ENSMUST00000042444.6
|
Arhgap36
|
Rho GTPase activating protein 36 |
chr17_-_45685973 | 5.61 |
ENSMUST00000145873.1
|
Tmem63b
|
transmembrane protein 63b |
chr1_+_180641330 | 5.59 |
ENSMUST00000085804.5
|
Lin9
|
lin-9 homolog (C. elegans) |
chr7_+_126847908 | 5.59 |
ENSMUST00000147257.1
ENSMUST00000139174.1 |
Doc2a
|
double C2, alpha |
chr7_-_4778141 | 5.58 |
ENSMUST00000094892.5
|
Il11
|
interleukin 11 |
chr5_+_36868467 | 5.53 |
ENSMUST00000031003.7
|
Ppp2r2c
|
protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform |
chr17_+_46297917 | 5.53 |
ENSMUST00000166617.1
ENSMUST00000170271.1 |
Dlk2
|
delta-like 2 homolog (Drosophila) |
chr7_-_48881596 | 5.48 |
ENSMUST00000119223.1
|
E2f8
|
E2F transcription factor 8 |
chr7_+_141061274 | 5.47 |
ENSMUST00000048002.5
|
B4galnt4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr11_+_120949053 | 5.37 |
ENSMUST00000154187.1
ENSMUST00000100130.3 ENSMUST00000129473.1 ENSMUST00000168579.1 |
Slc16a3
|
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
chr7_+_27653906 | 5.35 |
ENSMUST00000008088.7
|
Ttc9b
|
tetratricopeptide repeat domain 9B |
chr2_-_181135220 | 5.34 |
ENSMUST00000016491.7
|
Kcnq2
|
potassium voltage-gated channel, subfamily Q, member 2 |
chr14_+_3412614 | 5.32 |
ENSMUST00000170123.1
|
Gm10409
|
predicted gene 10409 |
chr1_-_21961581 | 5.29 |
ENSMUST00000029667.6
ENSMUST00000173058.1 ENSMUST00000173404.1 |
Kcnq5
|
potassium voltage-gated channel, subfamily Q, member 5 |
chr12_+_80518990 | 5.29 |
ENSMUST00000021558.6
|
Galnt16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
chr2_-_32312162 | 5.24 |
ENSMUST00000155269.1
|
Dnm1
|
dynamin 1 |
chr5_-_115194283 | 5.24 |
ENSMUST00000112113.1
|
Cabp1
|
calcium binding protein 1 |
chr2_+_3713478 | 5.21 |
ENSMUST00000115053.2
|
Fam107b
|
family with sequence similarity 107, member B |
chr15_+_99126513 | 5.21 |
ENSMUST00000063517.4
|
Spats2
|
spermatogenesis associated, serine-rich 2 |
chr6_-_39557830 | 5.20 |
ENSMUST00000036877.3
ENSMUST00000154149.1 |
Dennd2a
|
DENN/MADD domain containing 2A |
chr19_-_42431778 | 5.19 |
ENSMUST00000048630.6
|
Crtac1
|
cartilage acidic protein 1 |
chr12_-_109068173 | 5.19 |
ENSMUST00000073156.7
|
Begain
|
brain-enriched guanylate kinase-associated |
chr5_+_120649188 | 5.18 |
ENSMUST00000156722.1
|
Rasal1
|
RAS protein activator like 1 (GAP1 like) |
chr9_+_47530173 | 5.15 |
ENSMUST00000114548.1
ENSMUST00000152459.1 ENSMUST00000143026.1 ENSMUST00000085909.2 ENSMUST00000114547.1 ENSMUST00000034581.3 |
Cadm1
|
cell adhesion molecule 1 |
chr7_+_100227311 | 5.09 |
ENSMUST00000084935.3
|
Pgm2l1
|
phosphoglucomutase 2-like 1 |
chr17_+_25717489 | 5.09 |
ENSMUST00000115108.3
|
Gng13
|
guanine nucleotide binding protein (G protein), gamma 13 |
chr4_+_46450892 | 5.06 |
ENSMUST00000102926.4
|
Anp32b
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
chr19_+_60755947 | 5.05 |
ENSMUST00000088237.4
|
Nanos1
|
nanos homolog 1 (Drosophila) |
chr11_-_118909487 | 5.04 |
ENSMUST00000117731.1
ENSMUST00000106278.2 ENSMUST00000120061.1 ENSMUST00000017576.4 |
Rbfox3
|
RNA binding protein, fox-1 homolog (C. elegans) 3 |
chr12_-_11265768 | 5.04 |
ENSMUST00000166117.1
|
Gen1
|
Gen homolog 1, endonuclease (Drosophila) |
chr9_-_24503127 | 5.03 |
ENSMUST00000142064.1
ENSMUST00000170356.1 |
Dpy19l1
|
dpy-19-like 1 (C. elegans) |
chr2_+_154791344 | 5.03 |
ENSMUST00000140713.1
ENSMUST00000137333.1 |
Raly
a
|
hnRNP-associated with lethal yellow nonagouti |
chr12_-_102704896 | 5.00 |
ENSMUST00000178697.1
ENSMUST00000046518.5 |
Itpk1
|
inositol 1,3,4-triphosphate 5/6 kinase |
chr5_-_136244865 | 5.00 |
ENSMUST00000005188.9
|
Sh2b2
|
SH2B adaptor protein 2 |
chr15_+_83779999 | 4.99 |
ENSMUST00000046168.5
|
Mpped1
|
metallophosphoesterase domain containing 1 |
chr7_+_143107252 | 4.98 |
ENSMUST00000009689.4
|
Kcnq1
|
potassium voltage-gated channel, subfamily Q, member 1 |
chr8_+_57511833 | 4.91 |
ENSMUST00000067925.6
|
Hmgb2
|
high mobility group box 2 |
chr8_-_53638945 | 4.91 |
ENSMUST00000047768.4
|
Neil3
|
nei like 3 (E. coli) |
chr2_+_31245801 | 4.90 |
ENSMUST00000000199.7
|
Ncs1
|
neuronal calcium sensor 1 |
chr15_+_78428564 | 4.90 |
ENSMUST00000166142.2
ENSMUST00000162517.1 ENSMUST00000089414.4 |
Kctd17
|
potassium channel tetramerisation domain containing 17 |
chr13_-_69611421 | 4.88 |
ENSMUST00000091514.5
|
Srd5a1
|
steroid 5 alpha-reductase 1 |
chr1_+_75382114 | 4.87 |
ENSMUST00000113590.1
ENSMUST00000148515.1 |
Speg
|
SPEG complex locus |
chr10_+_80356459 | 4.86 |
ENSMUST00000039836.8
ENSMUST00000105351.1 |
Plk5
|
polo-like kinase 5 |
chr16_+_93883895 | 4.84 |
ENSMUST00000023666.4
ENSMUST00000117099.1 ENSMUST00000142316.1 |
Chaf1b
|
chromatin assembly factor 1, subunit B (p60) |
chr17_+_83350925 | 4.78 |
ENSMUST00000096766.4
ENSMUST00000112363.2 ENSMUST00000049503.8 |
Eml4
|
echinoderm microtubule associated protein like 4 |
chr8_-_92355764 | 4.75 |
ENSMUST00000180102.1
ENSMUST00000179421.1 ENSMUST00000179222.1 ENSMUST00000179029.1 |
4933436C20Rik
|
RIKEN cDNA 4933436C20 gene |
chr13_+_55445301 | 4.75 |
ENSMUST00000001115.8
ENSMUST00000099482.3 |
Grk6
|
G protein-coupled receptor kinase 6 |
chr19_+_47178820 | 4.75 |
ENSMUST00000111808.3
|
Neurl1a
|
neuralized homolog 1A (Drosophila) |
chr14_+_45219993 | 4.72 |
ENSMUST00000146150.1
|
Gpr137c
|
G protein-coupled receptor 137C |
chr19_+_18670780 | 4.70 |
ENSMUST00000025632.9
|
2410127L17Rik
|
RIKEN cDNA 2410127L17 gene |
chr4_-_91372028 | 4.68 |
ENSMUST00000107110.1
ENSMUST00000008633.8 ENSMUST00000107118.1 |
Elavl2
|
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) |
chr17_-_25433263 | 4.67 |
ENSMUST00000159623.1
|
Cacna1h
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr4_-_43499608 | 4.67 |
ENSMUST00000136005.1
ENSMUST00000054538.6 |
Arhgef39
|
Rho guanine nucleotide exchange factor (GEF) 39 |
chrX_+_73639414 | 4.66 |
ENSMUST00000019701.8
|
Dusp9
|
dual specificity phosphatase 9 |
chr7_-_48881032 | 4.66 |
ENSMUST00000058745.8
|
E2f8
|
E2F transcription factor 8 |
chr4_+_129985098 | 4.63 |
ENSMUST00000106017.1
ENSMUST00000121049.1 |
Bai2
|
brain-specific angiogenesis inhibitor 2 |
chr5_-_107987003 | 4.63 |
ENSMUST00000145239.1
ENSMUST00000031198.4 |
Fam69a
|
family with sequence similarity 69, member A |
chr10_+_127078886 | 4.63 |
ENSMUST00000039259.6
|
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr2_-_152398046 | 4.62 |
ENSMUST00000063332.8
ENSMUST00000182625.1 |
Sox12
|
SRY-box containing gene 12 |
chr11_-_4947991 | 4.62 |
ENSMUST00000093369.4
|
Nefh
|
neurofilament, heavy polypeptide |
chr10_-_127534540 | 4.59 |
ENSMUST00000095266.2
|
Nxph4
|
neurexophilin 4 |
chr6_-_85513586 | 4.59 |
ENSMUST00000095759.3
|
Egr4
|
early growth response 4 |
chr7_-_44869788 | 4.58 |
ENSMUST00000046575.9
|
Ptov1
|
prostate tumor over expressed gene 1 |
chr1_-_192855723 | 4.57 |
ENSMUST00000155579.1
|
Sertad4
|
SERTA domain containing 4 |
chr1_+_91801453 | 4.57 |
ENSMUST00000007949.3
|
Twist2
|
twist basic helix-loop-helix transcription factor 2 |
chr13_-_55513427 | 4.57 |
ENSMUST00000069929.6
ENSMUST00000069968.6 ENSMUST00000131306.1 ENSMUST00000046246.6 |
Pdlim7
|
PDZ and LIM domain 7 |
chr2_+_145167706 | 4.55 |
ENSMUST00000110007.1
|
Slc24a3
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
chr2_-_31845925 | 4.52 |
ENSMUST00000028188.7
|
Fibcd1
|
fibrinogen C domain containing 1 |
chr2_-_129297205 | 4.52 |
ENSMUST00000052708.6
|
Ckap2l
|
cytoskeleton associated protein 2-like |
chr13_-_107022027 | 4.51 |
ENSMUST00000117539.1
ENSMUST00000122233.1 ENSMUST00000022204.9 ENSMUST00000159772.1 |
Kif2a
|
kinesin family member 2A |
chr10_-_127666598 | 4.49 |
ENSMUST00000099157.3
|
Nab2
|
Ngfi-A binding protein 2 |
chr4_-_149774238 | 4.49 |
ENSMUST00000105686.2
|
Slc25a33
|
solute carrier family 25, member 33 |
chr7_-_133123409 | 4.48 |
ENSMUST00000170459.1
ENSMUST00000166400.1 |
Ctbp2
|
C-terminal binding protein 2 |
chr10_-_5805412 | 4.47 |
ENSMUST00000019907.7
|
Fbxo5
|
F-box protein 5 |
chr3_-_69044697 | 4.47 |
ENSMUST00000136512.1
ENSMUST00000143454.1 ENSMUST00000107802.1 |
Trim59
|
tripartite motif-containing 59 |
chr10_-_127666673 | 4.47 |
ENSMUST00000026469.2
|
Nab2
|
Ngfi-A binding protein 2 |
chr7_+_64501687 | 4.45 |
ENSMUST00000032732.8
|
Apba2
|
amyloid beta (A4) precursor protein-binding, family A, member 2 |
chr2_+_163054682 | 4.44 |
ENSMUST00000018005.3
|
Mybl2
|
myeloblastosis oncogene-like 2 |
chr13_-_55488038 | 4.40 |
ENSMUST00000109921.2
ENSMUST00000109923.2 ENSMUST00000021950.8 |
Dbn1
|
drebrin 1 |
chr15_+_82274935 | 4.40 |
ENSMUST00000023095.6
|
Sept3
|
septin 3 |
chr12_+_105336922 | 4.39 |
ENSMUST00000180503.1
|
2810011L19Rik
|
RIKEN cDNA 2810011L19 gene |
chr4_-_105109829 | 4.38 |
ENSMUST00000030243.7
|
Prkaa2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit |
chr1_-_153332724 | 4.37 |
ENSMUST00000027752.8
|
Lamc1
|
laminin, gamma 1 |
chr4_+_52439235 | 4.36 |
ENSMUST00000117280.1
ENSMUST00000102915.3 ENSMUST00000142227.1 |
Smc2
|
structural maintenance of chromosomes 2 |
chr17_+_27556641 | 4.36 |
ENSMUST00000119486.1
ENSMUST00000118599.1 |
Hmga1
|
high mobility group AT-hook 1 |
chr2_-_136387929 | 4.35 |
ENSMUST00000035264.2
ENSMUST00000077200.3 |
Pak7
|
p21 protein (Cdc42/Rac)-activated kinase 7 |
chr6_-_148946146 | 4.34 |
ENSMUST00000132696.1
|
Fam60a
|
family with sequence similarity 60, member A |
chr5_-_134747241 | 4.30 |
ENSMUST00000015138.9
|
Eln
|
elastin |
chr17_+_27556613 | 4.30 |
ENSMUST00000117600.1
ENSMUST00000114888.3 |
Hmga1
|
high mobility group AT-hook 1 |
chr2_+_3713449 | 4.29 |
ENSMUST00000027965.4
|
Fam107b
|
family with sequence similarity 107, member B |
chr15_+_82275197 | 4.29 |
ENSMUST00000116423.1
|
Sept3
|
septin 3 |
chr5_-_38159457 | 4.28 |
ENSMUST00000031009.4
|
Nsg1
|
neuron specific gene family member 1 |
chr4_+_11191354 | 4.28 |
ENSMUST00000170901.1
|
Ccne2
|
cyclin E2 |
chr1_+_172482199 | 4.22 |
ENSMUST00000135267.1
ENSMUST00000052629.6 ENSMUST00000111235.2 |
Igsf9
|
immunoglobulin superfamily, member 9 |
chr2_+_139678178 | 4.21 |
ENSMUST00000184404.1
ENSMUST00000099307.3 |
Ism1
|
isthmin 1 homolog (zebrafish) |
chr5_-_96161742 | 4.21 |
ENSMUST00000129646.1
ENSMUST00000113005.2 ENSMUST00000154500.1 ENSMUST00000141383.1 |
Cnot6l
|
CCR4-NOT transcription complex, subunit 6-like |
chr2_+_158768083 | 4.21 |
ENSMUST00000029183.2
|
Fam83d
|
family with sequence similarity 83, member D |
chr2_+_167062934 | 4.20 |
ENSMUST00000125674.1
|
1500012F01Rik
|
RIKEN cDNA 1500012F01 gene |
chr15_-_64312636 | 4.20 |
ENSMUST00000177083.1
ENSMUST00000177371.1 |
Asap1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
chr5_-_142608785 | 4.20 |
ENSMUST00000037048.7
|
Mmd2
|
monocyte to macrophage differentiation-associated 2 |
chr5_-_140649018 | 4.19 |
ENSMUST00000042661.3
|
Ttyh3
|
tweety homolog 3 (Drosophila) |
chr4_+_8690399 | 4.17 |
ENSMUST00000127476.1
|
Chd7
|
chromodomain helicase DNA binding protein 7 |
chr5_-_8422582 | 4.17 |
ENSMUST00000168500.1
ENSMUST00000002368.9 |
Dbf4
|
DBF4 homolog (S. cerevisiae) |
chr8_+_124793013 | 4.13 |
ENSMUST00000167588.1
|
Trim67
|
tripartite motif-containing 67 |
chr2_+_157560078 | 4.12 |
ENSMUST00000153739.2
ENSMUST00000173595.1 ENSMUST00000109526.1 ENSMUST00000173839.1 ENSMUST00000173041.1 ENSMUST00000173793.1 ENSMUST00000172487.1 ENSMUST00000088484.5 |
Nnat
|
neuronatin |
chr9_+_88327592 | 4.11 |
ENSMUST00000034992.6
|
Nt5e
|
5' nucleotidase, ecto |
chr3_+_88532314 | 4.11 |
ENSMUST00000172699.1
|
Mex3a
|
mex3 homolog A (C. elegans) |
chr10_+_40883469 | 4.07 |
ENSMUST00000019975.7
|
Wasf1
|
WAS protein family, member 1 |
chr7_+_82867327 | 4.07 |
ENSMUST00000082237.5
|
Mex3b
|
mex3 homolog B (C. elegans) |
chrX_-_104201126 | 4.03 |
ENSMUST00000056502.6
ENSMUST00000118314.1 |
C77370
|
expressed sequence C77370 |
chr2_+_72476159 | 4.00 |
ENSMUST00000102691.4
|
Cdca7
|
cell division cycle associated 7 |
chr17_-_45686214 | 3.99 |
ENSMUST00000113523.2
|
Tmem63b
|
transmembrane protein 63b |
chr4_-_137796350 | 3.98 |
ENSMUST00000030551.4
|
Alpl
|
alkaline phosphatase, liver/bone/kidney |
chr11_+_78178651 | 3.97 |
ENSMUST00000092880.7
ENSMUST00000127587.1 ENSMUST00000108338.1 |
Tlcd1
|
TLC domain containing 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 16.8 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
4.5 | 13.4 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
4.1 | 12.2 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
3.6 | 10.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
3.6 | 3.6 | GO:1904009 | response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
3.4 | 13.6 | GO:0006272 | leading strand elongation(GO:0006272) |
3.1 | 3.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
3.0 | 8.9 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
2.5 | 7.5 | GO:1990523 | bone regeneration(GO:1990523) |
2.5 | 7.5 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
2.5 | 7.4 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
2.5 | 7.4 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
2.3 | 16.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
2.3 | 11.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
2.2 | 6.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.2 | 10.9 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
2.2 | 6.5 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
2.0 | 12.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
2.0 | 4.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
2.0 | 6.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
2.0 | 6.0 | GO:0021623 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
2.0 | 21.7 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.9 | 5.8 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
1.9 | 5.6 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
1.9 | 11.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.8 | 16.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.8 | 5.5 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
1.8 | 8.9 | GO:0030421 | defecation(GO:0030421) |
1.8 | 3.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.7 | 5.2 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
1.7 | 13.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.7 | 8.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.7 | 6.8 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
1.7 | 11.8 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
1.7 | 5.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.7 | 5.0 | GO:0060032 | notochord regression(GO:0060032) |
1.6 | 3.2 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
1.6 | 7.8 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
1.6 | 6.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
1.5 | 4.6 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
1.5 | 4.6 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
1.5 | 13.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.5 | 15.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.5 | 4.5 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
1.5 | 6.0 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.5 | 3.0 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
1.5 | 4.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.5 | 13.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.4 | 11.5 | GO:0001842 | neural fold formation(GO:0001842) |
1.4 | 1.4 | GO:0007521 | muscle cell fate determination(GO:0007521) |
1.4 | 4.3 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
1.4 | 1.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.4 | 4.2 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
1.4 | 8.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.4 | 12.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
1.4 | 4.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.4 | 4.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
1.4 | 2.8 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
1.4 | 4.1 | GO:1901355 | response to rapamycin(GO:1901355) |
1.4 | 4.1 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.4 | 4.1 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
1.4 | 5.5 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
1.4 | 8.2 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
1.3 | 5.3 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
1.3 | 4.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.3 | 4.0 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) |
1.3 | 35.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.3 | 3.9 | GO:0072720 | response to dithiothreitol(GO:0072720) |
1.3 | 6.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
1.3 | 6.4 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.3 | 6.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.3 | 5.1 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
1.3 | 3.8 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.3 | 5.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.3 | 11.5 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
1.3 | 5.0 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
1.3 | 8.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.3 | 6.3 | GO:0008355 | olfactory learning(GO:0008355) |
1.3 | 5.0 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.2 | 1.2 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
1.2 | 2.5 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
1.2 | 2.4 | GO:0061552 | vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) ganglion morphogenesis(GO:0061552) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) |
1.2 | 1.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.2 | 4.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.2 | 7.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.2 | 2.4 | GO:0051309 | female meiosis chromosome separation(GO:0051309) |
1.2 | 3.5 | GO:0070845 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
1.2 | 7.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.2 | 3.5 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
1.2 | 3.5 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
1.2 | 4.6 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
1.1 | 5.6 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
1.1 | 1.1 | GO:1902688 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
1.1 | 3.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.1 | 5.5 | GO:0015888 | thiamine transport(GO:0015888) |
1.1 | 9.9 | GO:0033504 | floor plate development(GO:0033504) |
1.1 | 3.3 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
1.1 | 4.4 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
1.1 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.1 | 3.2 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
1.1 | 8.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.1 | 8.5 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
1.1 | 4.2 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
1.1 | 1.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.0 | 7.2 | GO:0015862 | uridine transport(GO:0015862) |
1.0 | 1.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.0 | 3.1 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
1.0 | 6.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
1.0 | 2.0 | GO:0060220 | camera-type eye photoreceptor cell fate commitment(GO:0060220) |
1.0 | 1.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
1.0 | 38.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
1.0 | 3.1 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
1.0 | 1.0 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
1.0 | 5.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.0 | 2.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.0 | 2.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.0 | 8.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.0 | 4.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
1.0 | 2.0 | GO:0060166 | olfactory pit development(GO:0060166) |
1.0 | 4.9 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.0 | 1.9 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
1.0 | 8.7 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
1.0 | 3.8 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.0 | 5.7 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.9 | 1.9 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.9 | 3.8 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.9 | 3.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.9 | 5.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.9 | 2.8 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.9 | 4.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.9 | 1.9 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.9 | 0.9 | GO:0070640 | vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.9 | 2.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.9 | 2.7 | GO:0015881 | creatine transport(GO:0015881) |
0.9 | 1.8 | GO:2000417 | positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) negative regulation of eosinophil migration(GO:2000417) |
0.9 | 6.4 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.9 | 1.8 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.9 | 2.7 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.9 | 9.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.9 | 1.8 | GO:1902569 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
0.9 | 5.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.9 | 3.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.9 | 8.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.9 | 5.3 | GO:0032796 | uropod organization(GO:0032796) |
0.9 | 2.7 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.9 | 5.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.9 | 2.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.9 | 2.6 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.9 | 6.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.9 | 2.6 | GO:1901254 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
0.9 | 4.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.9 | 3.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.9 | 2.6 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.9 | 7.8 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.9 | 5.2 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.9 | 6.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.9 | 4.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.9 | 5.2 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.9 | 8.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.9 | 1.7 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
0.8 | 5.9 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.8 | 0.8 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
0.8 | 3.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.8 | 3.3 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.8 | 0.8 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.8 | 2.5 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.8 | 3.3 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.8 | 2.5 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.8 | 1.7 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.8 | 5.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.8 | 5.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.8 | 2.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.8 | 4.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.8 | 0.8 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.8 | 2.5 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.8 | 4.9 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.8 | 1.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.8 | 1.6 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.8 | 8.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.8 | 1.6 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.8 | 2.4 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.8 | 4.8 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.8 | 6.4 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.8 | 2.4 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.8 | 6.3 | GO:0042637 | catagen(GO:0042637) |
0.8 | 5.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.8 | 6.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.8 | 3.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.8 | 7.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.8 | 4.7 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.8 | 3.9 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.8 | 3.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 2.3 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.8 | 2.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.8 | 4.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.8 | 3.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.8 | 2.3 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
0.7 | 0.7 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.7 | 2.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.7 | 4.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.7 | 2.2 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.7 | 2.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.7 | 2.2 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.7 | 3.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.7 | 13.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.7 | 2.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.7 | 7.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.7 | 3.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.7 | 2.1 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.7 | 2.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.7 | 1.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.7 | 2.1 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.7 | 2.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.7 | 2.1 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.7 | 10.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.7 | 0.7 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.7 | 2.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.7 | 2.8 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.7 | 2.1 | GO:0072014 | proximal tubule development(GO:0072014) |
0.7 | 2.7 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
0.7 | 14.8 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.7 | 25.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.7 | 1.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.7 | 2.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.7 | 1.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 2.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 6.6 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.7 | 4.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.7 | 5.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.7 | 2.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.7 | 0.7 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.7 | 2.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.6 | 4.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.6 | 4.5 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.6 | 1.3 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.6 | 0.6 | GO:0086047 | Purkinje myocyte action potential(GO:0086017) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.6 | 0.6 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.6 | 7.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.6 | 5.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.6 | 2.6 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.6 | 1.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.6 | 3.1 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.6 | 3.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.6 | 3.8 | GO:0019985 | translesion synthesis(GO:0019985) |
0.6 | 2.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.6 | 0.6 | GO:0090427 | activation of meiosis(GO:0090427) |
0.6 | 3.7 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.6 | 1.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.6 | 0.6 | GO:0060067 | cervix development(GO:0060067) |
0.6 | 1.8 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.6 | 2.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.6 | 4.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.6 | 3.6 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.6 | 3.6 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.6 | 2.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.6 | 3.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.6 | 3.6 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.6 | 0.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.6 | 1.8 | GO:0051977 | lysophospholipid transport(GO:0051977) |
0.6 | 1.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.6 | 3.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.6 | 2.9 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.6 | 1.2 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.6 | 2.3 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
0.6 | 1.1 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.6 | 6.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.6 | 1.1 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.6 | 0.6 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.6 | 3.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 2.8 | GO:0048478 | replication fork protection(GO:0048478) |
0.6 | 3.4 | GO:0060613 | fat pad development(GO:0060613) |
0.6 | 10.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.6 | 3.9 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.6 | 1.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.6 | 4.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.6 | 7.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 6.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.6 | 0.6 | GO:0048254 | snoRNA localization(GO:0048254) |
0.6 | 3.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 2.8 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.6 | 0.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.6 | 0.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 1.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.5 | 13.1 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.5 | 1.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.5 | 2.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.5 | 1.6 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.5 | 1.6 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.5 | 8.7 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.5 | 1.6 | GO:0060912 | cardiac cell fate specification(GO:0060912) |
0.5 | 13.4 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.5 | 7.0 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.5 | 2.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 3.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.5 | 0.5 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.5 | 0.5 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.5 | 1.1 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
0.5 | 1.6 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.5 | 0.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.5 | 6.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.5 | 11.0 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.5 | 2.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.5 | 1.6 | GO:0021759 | globus pallidus development(GO:0021759) |
0.5 | 12.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.5 | 1.0 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.5 | 7.8 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.5 | 2.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 2.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 5.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.5 | 1.5 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.5 | 3.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 2.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 1.5 | GO:0051030 | snRNA transport(GO:0051030) |
0.5 | 1.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 2.0 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.5 | 0.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.5 | 2.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.5 | 2.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.5 | 2.5 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.5 | 4.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.5 | 4.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.5 | 2.0 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.5 | 0.5 | GO:0002188 | translation reinitiation(GO:0002188) |
0.5 | 1.0 | GO:0001705 | ectoderm formation(GO:0001705) |
0.5 | 4.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.5 | 0.5 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.5 | 2.5 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.5 | 2.9 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.5 | 2.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.5 | 1.9 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.5 | 1.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.5 | 2.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.5 | 0.5 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.5 | 0.5 | GO:0046533 | regulation of photoreceptor cell differentiation(GO:0046532) negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.5 | 6.3 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.5 | 0.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.5 | 1.4 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.5 | 1.9 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.5 | 2.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 5.7 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.5 | 2.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.5 | 1.4 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.5 | 1.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
0.5 | 3.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.5 | 1.0 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.5 | 2.4 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.5 | 0.5 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.5 | 3.3 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
0.5 | 1.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 2.8 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.5 | 5.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.5 | 1.4 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.5 | 0.9 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.5 | 1.9 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.5 | 1.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 1.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.5 | 0.5 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.5 | 1.8 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.5 | 6.0 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.5 | 0.9 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.5 | 0.5 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 0.5 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
0.5 | 0.9 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.5 | 1.4 | GO:0046618 | drug export(GO:0046618) |
0.5 | 3.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 0.5 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.5 | 2.7 | GO:0030578 | PML body organization(GO:0030578) |
0.5 | 1.8 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.5 | 7.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.5 | 0.5 | GO:0099543 | trans-synaptic signaling by soluble gas(GO:0099543) |
0.5 | 1.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.4 | 1.3 | GO:0032916 | positive regulation of transforming growth factor beta3 production(GO:0032916) |
0.4 | 5.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 2.7 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 13.4 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.4 | 2.7 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 1.3 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.4 | 1.3 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
0.4 | 0.9 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.4 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 0.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 2.2 | GO:0045994 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.4 | 0.4 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.4 | 1.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 1.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 1.3 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 1.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 15.7 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.4 | 3.4 | GO:0060068 | vagina development(GO:0060068) |
0.4 | 5.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.4 | 2.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 2.5 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.4 | 5.4 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.4 | 5.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 0.4 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.4 | 2.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.4 | 0.8 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.4 | 0.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.4 | 0.4 | GO:1990773 | regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) |
0.4 | 1.2 | GO:1903660 | transforming growth factor beta activation(GO:0036363) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.4 | 2.4 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.4 | 0.4 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.4 | 4.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 1.6 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.4 | 2.4 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.4 | 0.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 1.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.4 | 5.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 0.8 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.4 | 3.9 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.4 | 1.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 2.0 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.4 | 6.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 2.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 1.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.4 | 0.4 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.4 | 1.5 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.4 | 1.5 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.4 | 1.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 1.9 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.4 | 5.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.4 | 1.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 0.4 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.4 | 7.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 0.4 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.4 | 3.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 1.9 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.4 | 1.1 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.4 | 1.5 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.4 | 2.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.4 | 1.5 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.4 | 12.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.4 | 21.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.4 | 1.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.4 | 9.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.4 | 1.1 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.4 | 2.9 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.4 | 1.1 | GO:1990046 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) positive regulation of mitochondrial DNA metabolic process(GO:1901860) stress-induced mitochondrial fusion(GO:1990046) |
0.4 | 1.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 0.7 | GO:0052312 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.4 | 0.4 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.4 | 1.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.4 | 2.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.4 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.4 | 2.9 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.4 | 2.1 | GO:0007135 | meiosis II(GO:0007135) |
0.4 | 2.5 | GO:0046931 | pore complex assembly(GO:0046931) nuclear pore complex assembly(GO:0051292) |
0.4 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.1 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 1.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.4 | 3.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 1.1 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 1.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.4 | 2.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 1.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 1.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.3 | 1.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.3 | 2.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 2.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.3 | 0.7 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.3 | 1.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.7 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 1.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 0.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 1.7 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.3 | 1.0 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.3 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 1.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 4.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.3 | 5.3 | GO:0051298 | centrosome duplication(GO:0051298) |
0.3 | 0.3 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.3 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 1.3 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 2.0 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.3 | 4.9 | GO:0034776 | response to histamine(GO:0034776) |
0.3 | 1.6 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 4.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 0.3 | GO:0019405 | alditol catabolic process(GO:0019405) |
0.3 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 2.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 2.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 1.0 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.3 | 1.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 3.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 2.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 4.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 1.9 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 3.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 4.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.3 | 0.9 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.3 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.3 | 10.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 1.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.3 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 1.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.9 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.3 | 6.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 0.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.3 | 3.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.3 | 1.5 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 0.9 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 2.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.3 | 5.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.3 | 8.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.3 | 0.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 2.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 1.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 3.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 2.7 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.3 | 1.5 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.3 | 0.3 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 1.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 3.3 | GO:0031297 | replication fork processing(GO:0031297) |
0.3 | 2.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 3.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 0.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 3.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 0.6 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.3 | 2.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.3 | 0.3 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.3 | 0.9 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.3 | 0.3 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.3 | 2.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.3 | 3.2 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.3 | 0.6 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.3 | 2.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.3 | 0.9 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 4.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 0.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 2.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 0.6 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.3 | 0.9 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.3 | 2.6 | GO:0060746 | parental behavior(GO:0060746) |
0.3 | 1.4 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.3 | 0.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 1.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 0.3 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.3 | 2.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.7 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.3 | 2.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 2.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 1.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.3 | 2.2 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.3 | 2.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 2.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 2.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 0.6 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.3 | 1.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 1.4 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.3 | 0.8 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.3 | 1.4 | GO:0048840 | otolith development(GO:0048840) |
0.3 | 2.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 3.0 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.3 | 1.1 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.3 | 0.5 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.3 | 4.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.8 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.3 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 1.6 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.3 | 0.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.3 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.3 | 0.5 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.3 | 0.8 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.3 | 0.3 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.3 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 1.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.3 | 2.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.3 | 0.5 | GO:0007398 | ectoderm development(GO:0007398) |
0.3 | 0.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.3 | 3.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.3 | 1.6 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) |
0.3 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 0.3 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.3 | 2.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.3 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 0.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.3 | 1.8 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 0.5 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.3 | 0.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.3 | 2.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.3 | 1.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 1.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 0.8 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.3 | 1.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 2.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.3 | 0.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 4.8 | GO:1903859 | regulation of dendrite extension(GO:1903859) |
0.3 | 3.8 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 0.5 | GO:0021854 | hypothalamus development(GO:0021854) |
0.3 | 0.8 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 1.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 0.2 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.2 | 1.7 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.2 | 0.5 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.2 | 1.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 1.2 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.2 | 4.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.2 | 1.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.5 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 0.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 2.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 1.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.2 | 2.7 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 0.7 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.2 | 1.2 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.2 | 5.0 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.2 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.2 | 1.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 2.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 0.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 0.5 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.2 | 0.2 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.2 | 1.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 1.0 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.2 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.7 | GO:0009644 | response to high light intensity(GO:0009644) |
0.2 | 1.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.5 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.2 | 8.3 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 0.2 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.2 | 4.5 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.2 | 0.9 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.2 | 1.4 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.2 | 0.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 1.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 0.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 1.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 8.9 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 1.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.2 | GO:0090172 | microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
0.2 | 1.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 0.7 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
0.2 | 2.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 1.3 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 1.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 1.8 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 0.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 1.1 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 3.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 1.3 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 2.8 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.9 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 20.1 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.2 | 2.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.2 | 1.3 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.2 | 0.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 1.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.6 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.2 | 1.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 0.6 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.2 | 1.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 1.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 0.4 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.2 | 1.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 2.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 1.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.8 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.2 | 4.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.2 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
0.2 | 0.6 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 1.4 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 1.0 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 1.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.2 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.2 | 0.8 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 0.8 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.2 | 1.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.8 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 1.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 1.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 0.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 1.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 0.6 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 1.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 0.2 | GO:0043217 | myelin maintenance(GO:0043217) |
0.2 | 3.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 1.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 7.9 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 1.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 1.4 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 1.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 1.0 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.2 | 1.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.8 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 1.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 0.6 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
0.2 | 1.9 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.4 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.2 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.6 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.2 | 1.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 3.7 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.8 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.2 | 1.5 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.2 | 0.4 | GO:0072716 | response to actinomycin D(GO:0072716) cellular response to actinomycin D(GO:0072717) |
0.2 | 0.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.8 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 6.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 0.6 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.2 | 0.9 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.2 | 2.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 0.4 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.2 | 0.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.4 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 2.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.6 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.2 | 5.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 2.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 2.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 3.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.7 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.2 | 4.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.5 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.2 | 0.5 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.2 | 2.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.2 | 0.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 2.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.4 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.2 | 0.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 3.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.2 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.2 | 1.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.2 | 0.4 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.2 | 2.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.2 | 0.2 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 1.7 | GO:0046959 | habituation(GO:0046959) |
0.2 | 0.7 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.2 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 2.2 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.2 | 0.5 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.2 | 2.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.5 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.2 | 2.9 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 2.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 1.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 1.2 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.2 | 3.2 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.2 | 6.5 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 0.3 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.2 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 1.8 | GO:0099628 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) protein localization to postsynaptic specialization membrane(GO:0099633) neurotransmitter receptor localization to postsynaptic specialization membrane(GO:0099645) |
0.2 | 1.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 2.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 3.9 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 1.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 1.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 0.6 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 0.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.3 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.2 | 0.5 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.2 | 2.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.2 | 1.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.5 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 4.7 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.2 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 8.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 0.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.2 | 1.7 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.2 | 0.5 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.2 | 0.9 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 0.8 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 0.4 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.1 | 2.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 1.2 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.4 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 1.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.9 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.9 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 0.4 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.4 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.1 | 0.3 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.1 | 1.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.1 | 0.1 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.1 | 2.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.1 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 1.1 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.1 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 1.0 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 1.7 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.3 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 1.0 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.1 | 1.5 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.7 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 1.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 1.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.1 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.1 | 0.8 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.1 | GO:0000819 | sister chromatid segregation(GO:0000819) |
0.1 | 0.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.8 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 1.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 1.0 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 1.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.3 | GO:2000209 | regulation of anoikis(GO:2000209) negative regulation of anoikis(GO:2000811) |
0.1 | 0.6 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 2.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) trophectodermal cell proliferation(GO:0001834) positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.1 | 3.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.4 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.1 | 0.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 3.5 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.4 | GO:0046032 | ADP catabolic process(GO:0046032) |
0.1 | 1.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.5 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.1 | 2.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.2 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.1 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.1 | 0.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.7 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 1.5 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.1 | 0.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 0.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.1 | 0.5 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.1 | 0.9 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.6 | GO:0043545 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 3.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.6 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.1 | 1.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 1.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 1.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.3 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.1 | 0.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.8 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.6 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.5 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 1.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 3.1 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 1.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 1.7 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 0.4 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.2 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.1 | 0.9 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.1 | 0.5 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.9 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.1 | 0.2 | GO:0060168 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.1 | 0.7 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 1.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.1 | 0.7 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.7 | GO:1903874 | ferrous iron transmembrane transport(GO:1903874) |
0.1 | 1.2 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.1 | 1.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.7 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.8 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.3 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.1 | 0.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.4 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.2 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.1 | 0.2 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 0.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 1.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 1.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 1.2 | GO:0030431 | sleep(GO:0030431) |
0.1 | 5.0 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.2 | GO:2000556 | regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.1 | 0.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.4 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.1 | 0.7 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 0.2 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.1 | 0.1 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.8 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 2.5 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.1 | 0.3 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
0.1 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.5 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.1 | 0.4 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.1 | 0.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.3 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.4 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.8 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 1.6 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.1 | 1.4 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.3 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 1.0 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 0.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.2 | GO:0042851 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.1 | 1.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.4 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 4.3 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.5 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.5 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.2 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
0.1 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.3 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.3 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.3 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.9 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 4.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.7 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.1 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.1 | 3.8 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.9 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.7 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 0.1 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 2.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.9 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.6 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 2.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.1 | 0.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.3 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.1 | 0.3 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 0.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 1.5 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 3.0 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.4 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.8 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.2 | GO:0060932 | atrioventricular bundle cell differentiation(GO:0003167) His-Purkinje system cell differentiation(GO:0060932) |
0.1 | 0.2 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.2 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 0.2 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.3 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.1 | 0.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.7 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.2 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.5 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 2.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.2 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.4 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.2 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 1.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.1 | 0.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 1.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.9 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.5 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 1.0 | GO:0007622 | rhythmic behavior(GO:0007622) |
0.1 | 1.4 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 1.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 2.1 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.5 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.0 | 0.3 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 1.4 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.0 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.0 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.0 | 1.5 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 1.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.0 | 0.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.0 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.1 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 1.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.4 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.0 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.6 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.3 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 1.9 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.0 | 0.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 1.0 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.0 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.4 | GO:0080184 | response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
0.0 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.2 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.0 | 0.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.2 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.0 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.2 | GO:0042436 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) indolalkylamine metabolic process(GO:0006586) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.2 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 1.4 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 0.2 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.0 | 0.0 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.1 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.0 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.1 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.0 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.0 | 0.4 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.0 | 0.1 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.0 | 0.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.8 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.0 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.0 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.0 | 0.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.6 | GO:0051384 | response to glucocorticoid(GO:0051384) |
0.0 | 0.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.0 | 0.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.0 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.0 | 0.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 1.4 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.4 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) proton-transporting two-sector ATPase complex assembly(GO:0070071) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 0.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.3 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 0.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 16.9 | GO:0090537 | CERF complex(GO:0090537) |
3.9 | 11.6 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
2.6 | 20.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
2.4 | 7.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
2.3 | 9.3 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
2.0 | 7.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.9 | 18.9 | GO:0044327 | dendritic spine head(GO:0044327) |
1.9 | 9.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.9 | 9.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.8 | 18.4 | GO:0000796 | condensin complex(GO:0000796) |
1.8 | 5.5 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
1.8 | 9.0 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
1.8 | 10.6 | GO:0000235 | astral microtubule(GO:0000235) |
1.8 | 7.0 | GO:1902737 | dendritic filopodium(GO:1902737) |
1.7 | 8.7 | GO:0031523 | Myb complex(GO:0031523) |
1.7 | 6.7 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.6 | 4.7 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
1.5 | 6.2 | GO:0071953 | elastic fiber(GO:0071953) |
1.5 | 13.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.5 | 4.5 | GO:1990423 | RZZ complex(GO:1990423) |
1.5 | 5.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.5 | 4.4 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
1.3 | 20.2 | GO:0042555 | MCM complex(GO:0042555) |
1.3 | 6.6 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
1.3 | 8.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.2 | 8.6 | GO:0001740 | Barr body(GO:0001740) |
1.2 | 21.0 | GO:0070938 | contractile ring(GO:0070938) |
1.2 | 6.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.1 | 5.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.1 | 2.3 | GO:0044317 | rod spherule(GO:0044317) |
1.1 | 3.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.1 | 5.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.1 | 3.2 | GO:0071920 | cleavage body(GO:0071920) |
1.0 | 11.4 | GO:0005642 | annulate lamellae(GO:0005642) |
1.0 | 9.3 | GO:0008278 | cohesin complex(GO:0008278) |
1.0 | 6.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.0 | 3.1 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
1.0 | 3.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.9 | 5.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.9 | 0.9 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.9 | 12.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.9 | 4.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.9 | 6.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.9 | 9.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.9 | 11.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.8 | 4.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.8 | 3.3 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.8 | 1.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.8 | 7.9 | GO:0005883 | neurofilament(GO:0005883) |
0.8 | 19.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.8 | 6.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.8 | 6.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.8 | 3.0 | GO:0008623 | CHRAC(GO:0008623) |
0.8 | 5.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.7 | 4.5 | GO:0098536 | deuterosome(GO:0098536) |
0.7 | 3.0 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
0.7 | 9.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.7 | 5.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.7 | 1.4 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.7 | 12.9 | GO:0005652 | nuclear lamina(GO:0005652) |
0.7 | 4.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.7 | 3.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 6.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.7 | 2.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.7 | 2.8 | GO:0044307 | dendritic branch(GO:0044307) |
0.7 | 0.7 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.7 | 7.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.7 | 2.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.7 | 4.6 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.7 | 4.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.7 | 1.3 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.7 | 3.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.6 | 4.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.6 | 10.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.6 | 7.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.6 | 0.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.6 | 2.5 | GO:0060187 | cell pole(GO:0060187) |
0.6 | 3.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 27.5 | GO:0044298 | cell body membrane(GO:0044298) |
0.6 | 1.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.6 | 3.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.6 | 4.8 | GO:0031415 | NatA complex(GO:0031415) |
0.6 | 2.4 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.6 | 5.9 | GO:0016589 | NURF complex(GO:0016589) |
0.6 | 5.3 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.6 | 0.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.6 | 1.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.6 | 23.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 9.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.6 | 9.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.6 | 0.6 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.6 | 2.3 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 2.8 | GO:0071547 | piP-body(GO:0071547) |
0.6 | 1.7 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.6 | 3.9 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.6 | 3.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.6 | 1.7 | GO:0035061 | interchromatin granule(GO:0035061) |
0.6 | 3.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 5.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 3.8 | GO:0005687 | U4 snRNP(GO:0005687) |
0.5 | 8.2 | GO:0010369 | chromocenter(GO:0010369) |
0.5 | 3.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.5 | 0.5 | GO:0035101 | FACT complex(GO:0035101) |
0.5 | 11.3 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 4.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.5 | 2.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 3.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 6.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 1.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 7.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 3.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 1.5 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.5 | 6.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 2.9 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.5 | 5.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.5 | 10.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.5 | 3.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.5 | 3.3 | GO:0089701 | U2AF(GO:0089701) |
0.5 | 13.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.5 | 11.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 7.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.5 | 4.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 5.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.5 | 1.4 | GO:0031251 | PAN complex(GO:0031251) |
0.5 | 13.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.5 | 7.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.5 | 0.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 0.9 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 1.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.4 | 1.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 3.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 5.6 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 6.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 1.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 1.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.4 | 2.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.4 | 15.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 3.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.4 | 14.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.4 | 3.3 | GO:0000243 | commitment complex(GO:0000243) |
0.4 | 2.1 | GO:0030689 | Noc complex(GO:0030689) |
0.4 | 9.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 0.4 | GO:0044301 | climbing fiber(GO:0044301) |
0.4 | 3.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.4 | 2.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 2.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 1.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.4 | 11.9 | GO:0005657 | replication fork(GO:0005657) |
0.4 | 0.8 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.4 | 1.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.4 | 1.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.4 | 2.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.4 | 4.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 3.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.4 | 3.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 1.1 | GO:0005940 | septin ring(GO:0005940) |
0.4 | 2.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.4 | 2.5 | GO:0000801 | central element(GO:0000801) |
0.4 | 1.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.4 | 14.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.4 | 1.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 3.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 34.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 5.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 11.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.3 | 10.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 1.7 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 1.0 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 1.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.3 | 2.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 0.7 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.3 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 2.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 5.2 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 0.6 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 1.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.3 | 25.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 13.3 | GO:0002102 | podosome(GO:0002102) |
0.3 | 3.8 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 1.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.3 | 3.4 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 1.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 4.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 5.5 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 14.9 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.3 | 1.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 1.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 0.9 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.3 | 13.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 1.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 20.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 2.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 3.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.3 | 0.8 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.3 | 3.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 1.6 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.3 | 5.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 6.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 0.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.3 | 0.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 0.8 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.3 | 1.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 2.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 0.8 | GO:0018444 | translation release factor complex(GO:0018444) |
0.3 | 1.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 2.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 2.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 2.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.3 | 1.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 4.0 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 4.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.7 | GO:0001939 | female pronucleus(GO:0001939) |
0.2 | 1.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 4.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 1.4 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.2 | 1.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.7 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 0.9 | GO:0014802 | terminal cisterna(GO:0014802) |
0.2 | 3.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 1.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 32.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 3.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 25.0 | GO:0005901 | caveola(GO:0005901) |
0.2 | 2.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 4.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 2.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 2.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 1.8 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 2.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.9 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 3.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 9.9 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 2.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 5.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 14.2 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.8 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.2 | 10.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.6 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.2 | 3.6 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 1.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 6.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 1.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 1.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 0.4 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.2 | 10.0 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 1.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 2.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 1.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 1.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 0.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 0.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 10.0 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.2 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.2 | 19.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 7.6 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 2.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 1.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 0.7 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 0.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 1.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 1.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 4.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 2.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 2.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 1.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 11.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 2.2 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.2 | 1.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 2.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 0.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 1.5 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 2.6 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.4 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.2 | 1.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 94.5 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 2.8 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 1.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 1.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 9.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.7 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.1 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.5 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.8 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 1.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 3.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 6.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.4 | GO:0030934 | collagen type XII trimer(GO:0005595) anchoring collagen complex(GO:0030934) |
0.1 | 1.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 10.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 2.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 9.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 2.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 5.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 3.6 | GO:0043034 | costamere(GO:0043034) |
0.1 | 20.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 2.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.5 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 8.4 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 1.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.3 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 0.4 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.6 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 5.4 | GO:0005814 | centriole(GO:0005814) |
0.1 | 7.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 9.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.7 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 0.2 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 2.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.2 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 1.0 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 1.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.2 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.1 | 0.2 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 3.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 2.6 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.3 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 3.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 2.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 5.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) omegasome(GO:1990462) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 15.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.2 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 1.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 1.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 9.8 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 4.1 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 3.1 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 0.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0035859 | Seh1-associated complex(GO:0035859) Iml1 complex(GO:1990130) |
0.0 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 4.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.5 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 1.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.3 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 0.3 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.3 | GO:0045171 | intercellular bridge(GO:0045171) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 12.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
3.0 | 9.0 | GO:0070052 | collagen V binding(GO:0070052) |
2.5 | 2.5 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
2.1 | 6.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.9 | 15.6 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
1.9 | 5.6 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
1.8 | 7.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
1.8 | 5.3 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
1.8 | 15.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.7 | 7.0 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
1.7 | 8.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.7 | 1.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.6 | 4.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
1.6 | 9.6 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.5 | 4.6 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
1.5 | 4.6 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
1.5 | 3.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.5 | 6.0 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
1.5 | 13.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.4 | 7.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
1.4 | 10.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.4 | 8.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.4 | 8.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.4 | 2.7 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
1.4 | 8.2 | GO:0002135 | CTP binding(GO:0002135) |
1.3 | 4.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.3 | 14.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.3 | 10.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.3 | 14.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.3 | 6.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.3 | 12.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.3 | 5.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
1.3 | 3.8 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
1.3 | 5.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.3 | 5.0 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.2 | 3.5 | GO:0008158 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
1.2 | 3.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.2 | 1.2 | GO:0001225 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription coactivator binding(GO:0001225) |
1.2 | 8.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.1 | 8.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.1 | 10.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.1 | 3.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.1 | 5.6 | GO:1990188 | euchromatin binding(GO:1990188) |
1.1 | 3.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.1 | 2.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.1 | 3.3 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
1.1 | 3.2 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
1.1 | 5.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
1.1 | 2.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
1.1 | 4.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.1 | 10.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.1 | 3.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
1.0 | 3.1 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
1.0 | 5.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.0 | 3.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
1.0 | 7.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.0 | 4.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.0 | 8.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.0 | 5.0 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.0 | 4.9 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.0 | 4.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.0 | 3.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.9 | 6.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.9 | 8.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.9 | 5.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.9 | 2.7 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.9 | 3.6 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.9 | 4.5 | GO:0008061 | chitin binding(GO:0008061) |
0.9 | 17.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.9 | 3.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.9 | 6.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.9 | 5.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.9 | 5.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.9 | 6.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.9 | 2.6 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.8 | 12.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.8 | 6.7 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.8 | 2.5 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.8 | 5.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.8 | 2.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.8 | 3.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.8 | 3.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.8 | 2.3 | GO:0070540 | stearic acid binding(GO:0070540) |
0.8 | 4.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.8 | 0.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.8 | 3.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.8 | 3.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.8 | 5.3 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.7 | 12.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.7 | 6.7 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.7 | 4.4 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.7 | 4.4 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 10.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.7 | 4.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.7 | 4.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.7 | 4.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.7 | 3.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.7 | 30.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.7 | 2.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.7 | 4.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.7 | 3.5 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.7 | 2.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.7 | 2.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 5.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.7 | 3.4 | GO:0070404 | NADH binding(GO:0070404) |
0.7 | 4.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.7 | 2.7 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.7 | 18.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.7 | 4.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.7 | 6.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.7 | 9.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.7 | 9.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.7 | 2.6 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.6 | 2.6 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.6 | 6.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.6 | 1.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.6 | 2.5 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.6 | 4.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.6 | 2.5 | GO:0005113 | patched binding(GO:0005113) |
0.6 | 3.7 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.6 | 1.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.6 | 1.8 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.6 | 4.9 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.6 | 4.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.6 | 3.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.6 | 6.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.6 | 3.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.6 | 2.4 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.6 | 5.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.6 | 3.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.6 | 1.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.6 | 4.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 1.1 | GO:0031403 | lithium ion binding(GO:0031403) |
0.6 | 2.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.6 | 3.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.6 | 5.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 13.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 1.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.5 | 17.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.5 | 0.5 | GO:0031208 | POZ domain binding(GO:0031208) |
0.5 | 6.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 1.6 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.5 | 19.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 2.7 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.5 | 3.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 2.1 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.5 | 1.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.5 | 15.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.5 | 2.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 2.1 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.5 | 1.6 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.5 | 3.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.5 | 4.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 8.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 4.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.5 | 3.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.5 | 2.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.5 | 2.0 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.5 | 3.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 2.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 2.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 3.9 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.5 | 1.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.5 | 1.4 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.5 | 1.4 | GO:0080130 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.5 | 2.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.5 | 4.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.5 | 14.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 7.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 1.9 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.5 | 1.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.5 | 1.4 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.5 | 0.5 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.5 | 1.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 6.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 0.9 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.5 | 1.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 6.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 3.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 1.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 4.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 2.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 3.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 2.6 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 2.6 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 4.4 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.4 | 4.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.4 | 1.3 | GO:0008431 | vitamin E binding(GO:0008431) |
0.4 | 2.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 1.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 3.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 3.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 2.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.4 | 1.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 2.0 | GO:0097617 | annealing activity(GO:0097617) |
0.4 | 1.6 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 2.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 2.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 0.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 0.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.4 | 2.4 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.4 | 7.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 7.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 5.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 2.8 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.4 | 0.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 1.2 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.4 | 2.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 1.6 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.4 | 2.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 9.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 4.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 10.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 1.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.4 | 1.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.4 | 27.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.4 | 1.5 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.4 | 8.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 2.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 0.8 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.4 | 1.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.4 | 16.7 | GO:0045182 | translation regulator activity(GO:0045182) |
0.4 | 13.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 0.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 7.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 1.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.4 | 7.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 3.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.1 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.4 | 2.6 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.4 | 3.7 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 0.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.4 | 0.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 1.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 7.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 16.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.4 | 6.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 0.4 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.3 | 2.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 1.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 1.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 6.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 2.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 5.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 1.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 2.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 5.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 0.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.3 | 2.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 1.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.3 | 3.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 1.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.3 | 1.6 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 1.0 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.3 | 4.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.0 | GO:0030613 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.3 | 2.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 1.6 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.3 | 2.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 2.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.3 | 4.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 0.9 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.3 | 4.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 0.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.3 | 4.7 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 4.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 0.9 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.3 | 2.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 1.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 5.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 2.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 2.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.3 | 2.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 0.9 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 6.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.3 | 0.9 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 8.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.3 | 28.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 3.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 9.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 2.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 3.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 1.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 3.3 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.3 | 10.1 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 6.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 0.9 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.3 | 14.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 4.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 1.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 47.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 2.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 4.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 6.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 2.0 | GO:0008527 | taste receptor activity(GO:0008527) |
0.3 | 0.3 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.3 | 0.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.3 | 1.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 0.8 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.3 | 7.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 2.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.3 | 3.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.3 | 12.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 5.7 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.3 | 5.4 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 2.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.3 | 4.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 2.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 0.5 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.3 | 2.1 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.3 | 2.4 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 4.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 7.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 0.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 0.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.3 | 3.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 4.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 1.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 1.5 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 1.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 9.8 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.2 | 1.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 5.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.7 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 2.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 1.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 1.9 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 0.7 | GO:0032356 | oxidized DNA binding(GO:0032356) |
0.2 | 1.9 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.2 | 7.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 3.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 0.5 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.2 | 5.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 12.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 1.4 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.9 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.2 | 1.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.1 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 0.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 2.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 1.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 4.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.7 | GO:0070122 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.2 | 5.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 1.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 4.8 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 6.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 1.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 0.6 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.2 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 12.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.9 | GO:0035276 | ethanol binding(GO:0035276) |
0.2 | 0.6 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
0.2 | 1.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.2 | 0.6 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.2 | 1.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 4.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 2.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 2.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 15.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 2.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 7.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 0.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 1.2 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 21.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.4 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.2 | 1.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 1.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 2.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.6 | GO:0046911 | metal chelating activity(GO:0046911) |
0.2 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 11.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.6 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 1.0 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 34.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 0.8 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 8.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 2.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.4 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.2 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 2.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 4.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.7 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.2 | 0.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.4 | GO:0070990 | snRNP binding(GO:0070990) |
0.2 | 0.5 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 0.5 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.2 | 2.4 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.2 | 1.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 0.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.2 | 6.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 1.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 2.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 1.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 0.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.2 | 0.5 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.2 | 0.8 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.2 | 1.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 0.6 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.2 | 0.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 1.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 0.5 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.2 | 1.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.8 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.3 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.1 | GO:0003681 | bent DNA binding(GO:0003681) |
0.1 | 0.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.7 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.4 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 1.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 1.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 4.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 6.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 3.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.7 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 2.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 11.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.6 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 0.3 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 2.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 11.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.5 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 3.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 2.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 3.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 4.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.1 | 0.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 2.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 1.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 1.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.6 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.4 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.9 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 5.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.3 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.1 | 0.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.3 | GO:0036004 | GAF domain binding(GO:0036004) |
0.1 | 1.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.1 | 2.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.2 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
0.1 | 0.3 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.1 | 0.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 7.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 1.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 8.3 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.3 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
0.1 | 0.9 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.1 | GO:0016895 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.1 | 30.7 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 1.3 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.4 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.1 | 1.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 13.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 1.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.7 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.1 | 1.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 1.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 1.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.4 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 3.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.2 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.1 | 0.9 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 36.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.2 | GO:0019202 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
0.1 | 0.3 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.1 | 0.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 2.1 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 3.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.4 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 1.2 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 2.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 1.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 2.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 2.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.0 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.6 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.2 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.1 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.1 | 1.9 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 1.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 1.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 3.3 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.6 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.3 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 0.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.0 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 1.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 1.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.2 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 0.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.2 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 1.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.4 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 1.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.9 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 1.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 11.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.7 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.1 | GO:0004905 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) interferon binding(GO:0019961) type I interferon binding(GO:0019962) |
0.0 | 0.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.8 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.2 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.2 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.0 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 29.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.4 | 1.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.8 | 39.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.8 | 37.2 | PID ATR PATHWAY | ATR signaling pathway |
0.7 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.7 | 44.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 29.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.6 | 9.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.6 | 28.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.6 | 2.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.5 | 56.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 1.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 7.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.5 | 12.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.5 | 3.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 16.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 3.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.4 | 6.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.4 | 14.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 11.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 4.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 9.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 7.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 4.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 10.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 1.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 20.6 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 13.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 6.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 16.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 5.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 23.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 16.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 3.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 7.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 7.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 9.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 11.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 7.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 2.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 0.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 4.3 | PID ATM PATHWAY | ATM pathway |
0.2 | 0.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 2.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 14.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 1.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 9.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 11.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 1.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 3.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 9.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 1.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 5.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 3.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 5.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 4.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 1.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 1.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 4.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 3.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 2.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 4.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 4.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 6.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 5.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.6 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 4.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 2.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 3.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 3.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 14.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 3.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 2.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 2.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 3.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 5.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 10.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 2.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 2.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 20.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.6 | 32.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.6 | 26.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.6 | 1.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.5 | 44.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
1.3 | 18.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.2 | 1.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.0 | 4.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.9 | 10.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.9 | 5.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.9 | 23.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.9 | 9.5 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.8 | 14.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.8 | 12.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.8 | 9.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.8 | 9.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.8 | 36.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.7 | 9.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.7 | 2.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.7 | 11.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.7 | 6.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.7 | 5.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.6 | 2.5 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.6 | 18.6 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.6 | 8.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.6 | 3.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.6 | 12.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.5 | 14.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.5 | 5.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 6.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 0.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.5 | 7.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.5 | 10.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.5 | 30.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.5 | 12.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.5 | 0.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.5 | 17.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 9.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 8.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.4 | 16.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 11.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 10.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 7.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 7.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.4 | 4.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 6.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 5.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 2.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 0.4 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.3 | 4.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 2.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 11.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 3.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 17.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 24.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 7.6 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.3 | 5.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.3 | 6.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 2.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 5.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 4.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 3.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.3 | 6.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 18.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 13.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 22.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 3.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 16.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 0.2 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.2 | 2.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 12.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 2.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 15.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 7.9 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 0.4 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 4.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.2 | 9.3 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.2 | 2.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 2.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 3.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 2.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 6.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 7.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 12.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 2.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 4.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 0.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 3.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 2.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 1.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 0.5 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 0.5 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.2 | 2.5 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.2 | 7.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 1.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 2.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 3.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 1.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 4.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 2.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 6.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 3.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 5.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 2.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 3.9 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 9.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 5.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 2.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 3.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 5.6 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 1.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 2.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 1.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.6 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.1 | 1.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 1.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 4.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 2.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 3.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 15.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 2.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 2.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 4.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.8 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 4.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 1.3 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 1.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 2.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 4.3 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 1.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 1.2 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.0 | 2.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 3.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 4.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.5 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.0 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |